Abstract OT2-3-01: SGN-LIV1A: A phase 1 trial evaluating a novel antibody-drug conjugate in patients with LIV-1-positive breast cancer

Mapping Intimacies ◽

10.1158/1538-7445.sabcs14-ot2-3-01 ◽

2015 ◽

Author(s):

Andres Forero ◽

Howard Burris III ◽

Patricia LoRusso ◽

Jennifer Specht ◽

Kathy Miller ◽

...

Keyword(s):

Breast Cancer ◽

Phase 1 ◽

Antibody Drug Conjugate ◽

Phase 1 Trial ◽

Drug Conjugate ◽

Antibody Drug ◽

Positive Breast Cancer

Download Full-text

Abstract P1-18-16: A phase 1 study of ARX788, a HER2-targeting antibody-drug conjugate, in patients with metastatic HER2-positive breast cancer

10.1158/1538-7445.sabcs19-p1-18-16 ◽

2020 ◽

Author(s):

Xichun Hu ◽

Jian Zhang ◽

Dongmei Ji ◽

Gang Xia ◽

Yanping Ji ◽

...

Keyword(s):

Breast Cancer ◽

Phase 1 ◽

Antibody Drug Conjugate ◽

Her2 Positive ◽

Phase 1 Study ◽

Drug Conjugate ◽

Her2 Positive Breast Cancer ◽

Antibody Drug ◽

Positive Breast Cancer

Download Full-text

Abstract PS10-51: TAA013 a trastuzumab antibody drug conjugate phase I dose escalation study in recurrent her2 positive breast cancer

10.1158/1538-7445.sabcs20-ps10-51 ◽

2021 ◽

Author(s):

J M Liu ◽

Y M Yin ◽

Hao Wu ◽

W Li ◽

X Huang ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Dose Escalation ◽

Antibody Drug Conjugate ◽

Her2 Positive ◽

Dose Escalation Study ◽

Drug Conjugate ◽

Her2 Positive Breast Cancer ◽

Antibody Drug ◽

Positive Breast Cancer

Download Full-text

Abstract LB-001: Development and evaluation of T-Zap: a novel antibody-drug conjugate for the treatment of Her2 positive breast cancer

10.1158/1538-7445.am2018-lb-001 ◽

2018 ◽

Author(s):

Ricarda M. Hoffmann ◽

Silvia Crescioli ◽

David E. Thurston ◽

Sophia N. Karagiannis

Keyword(s):

Breast Cancer ◽

Antibody Drug Conjugate ◽

Her2 Positive ◽

Drug Conjugate ◽

Her2 Positive Breast Cancer ◽

Antibody Drug ◽

Positive Breast Cancer

Download Full-text

Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer

Journal of Medicinal Chemistry ◽

10.1021/jm500766w ◽

2014 ◽

Vol 57 (16) ◽

pp. 6949-6964 ◽

Author(s):

John M. Lambert ◽

Ravi V. J. Chari

Keyword(s):

Breast Cancer ◽

Trastuzumab Emtansine ◽

Antibody Drug Conjugate ◽

Her2 Positive ◽

Drug Conjugate ◽

Her2 Positive Breast Cancer ◽

Antibody Drug ◽

Positive Breast Cancer

Download Full-text

Abstract C126: PRLR ADC: A novel antibody drug-conjugate for the treatment of PRLR positive breast cancer

10.1158/1535-7163.targ-15-c126 ◽

2015 ◽

Author(s):

Marcus P. Kelly ◽

Sandra Coetzee ◽

Carlos Hickey ◽

Sosina Makonnen ◽

Frank Delfino ◽

...

Keyword(s):

Breast Cancer ◽

Antibody Drug Conjugate ◽

Drug Conjugate ◽

Antibody Drug ◽

Positive Breast Cancer

Download Full-text

Abstract PD3-14: Phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with heavily pretreated triple-negative metastatic breast cancer

10.1158/1538-7445.sabcs17-pd3-14 ◽

2018 ◽

Author(s):

S Modi ◽

L Pusztai ◽

A Forero ◽

M Mita ◽

KD Miller ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Triple Negative ◽

Phase 1 ◽

Metastatic Breast ◽

Antibody Drug Conjugate ◽

Phase 1 Study ◽

Drug Conjugate ◽

Heavily Pretreated ◽

Download Full-text

Abstract PD1-03: Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in HER3-overexpressing metastatic breast cancer: Updated results of a phase 1/2 trial

10.1158/1538-7445.sabcs18-pd1-03 ◽

2019 ◽

Author(s):

N Masuda ◽

K Yonemori ◽

S Takahashi ◽

T Kogawa ◽

T Nakayama ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase 1 ◽

Single Agent ◽

Metastatic Breast ◽

Antibody Drug Conjugate ◽

Drug Conjugate ◽

Download Full-text

Abstract P6-17-39: BAT8001, a potent anti-HER2 antibody-drug conjugate with a novel stable linker for the treatment of HER2-positive breast cancer

10.1158/1538-7445.sabcs18-p6-17-39 ◽

2019 ◽

Author(s):

W Tang ◽

X Deng ◽

Z Ou ◽

J Gan ◽

Q Dong ◽

...

Keyword(s):

Breast Cancer ◽

Antibody Drug Conjugate ◽

Her2 Positive ◽

Drug Conjugate ◽

Her2 Positive Breast Cancer ◽

Antibody Drug ◽

Positive Breast Cancer

Download Full-text

An Antibody–Drug Conjugate Is Effective in HER2-Positive Breast Cancer

Cancer Discovery ◽

10.1158/2159-8290.cd-rw2012-173 ◽

2012 ◽

Vol 2 (11) ◽

pp. 969.1-969

Keyword(s):

Breast Cancer ◽

Antibody Drug Conjugate ◽

Her2 Positive ◽

Drug Conjugate ◽

Her2 Positive Breast Cancer ◽

Antibody Drug ◽

Positive Breast Cancer

Download Full-text

Trastuzumab Emtansine: A Novel Antibody–Drug Conjugate for HER2-Positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-13-0541 ◽

2013 ◽

Vol 20 (1) ◽

pp. 15-20 ◽

Author(s):

Ian Krop ◽

Eric P. Winer

Keyword(s):

Breast Cancer ◽

Trastuzumab Emtansine ◽

Antibody Drug Conjugate ◽

Her2 Positive ◽

Drug Conjugate ◽

Her2 Positive Breast Cancer ◽

Antibody Drug ◽

Positive Breast Cancer

Download Full-text